Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

0
Player Avatar SnowBawl (< 20) Submitted: 9/9/2011 10:51:02 AM : Outperform Start Price: $28.62 BMY Score: +3.36

Hillary says so.

Report this Post Reply

Featured Broker Partners


Advertisement